Stockscreener 앱 받기
236.88
0.42%
-0.895
전일 마감가:
$237.77
열려 있는:
$239.1
하루 거래량:
111.60K
Relative Volume:
0.12
시가총액:
$26.16B
수익:
$11.28B
순이익/손실:
$1.07B
주가수익비율:
26.13
EPS:
9.0657
순현금흐름:
$1.33B
1주 성능:
-0.73%
1개월 성능:
+14.19%
6개월 성능:
+14.45%
1년 성능:
+32.24%
1일 변동 폭
$236.61
$240.00
1주일 범위
$232.28
$240.00
52주 변동 폭
$171.18
$240.13
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
Compare DGX vs TMO, DHR, NTRA, IDXX, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
236.97 | 26.24B | 11.28B | 1.07B | 1.33B | 9.0657 |
TMO
Thermo Fisher Scientific Inc
|
601.11 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.19 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
312.06 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
567.34 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86 - MarketBeat
Q2 2026 Quest Diagnostics Inc Earnings Call Transcript - GuruFocus
Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6 - marketscreener.com
Quest Diagnostics Sets Oct. 21 Date for Cash Dividend - Stock Titan
Diversified Management Inc. Lowers Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
IVY LANE CAPITAL MANAGEMENT, LLC's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC - MarketBeat
Quest Diagnostics Inc (DGX) Stock News Today - TradingKey
Quest Diagnostics Inc (DGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Quest Diagnostics (DGX) A Bargain Following Raised Guidance And Strong Quarterly Results? - Yahoo Finance
Quest Diagnostics (DGX) Stock May Be 32% Undervalued As Guidance Rises - Yahoo Finance
Arrowstreet Capital Limited Partnership Purchases New Shares in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Bought by Eastern Bank - MarketBeat
Royal Bank of Canada Has $38.91 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates - The Globe and Mail
Bank of America Corp DE Acquires 129,964 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Cetera Investment Advisers Acquires 8,362 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
California State Teachers Retirement System Sells 5,763 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Alpine Woods Capital Investors LLC Cuts Stock Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum? - Yahoo Finance
PR News | On the Move: Quest Diagnostics Names Chokshi IR ChiefThu., Jul. 30, 2026 - odwyerpr.com
Quest Diagnostics Incorporated $DGX Shares Sold by Lazard Asset Management LLC - MarketBeat
Quest Diagnostics Incorporated Stock 12‑Month Price Target Raised to $248.86, Implies 6% Upside - TradingView
OMERS ADMINISTRATION Corp Buys 10,073 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Insider at DGX (NYSE: DGX) plans sale of 1,600 common shares - Stock Titan
JPMorgan Adjusts Price Target on Quest Diagnostics to $250 From $220, Maintains Neutral Rating - marketscreener.com
DGX|Quest Diagnostics Inc|Price:231.750|Chg%:+3.890 - TradingKey
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Quest Diagnostics Inc (DGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 Quest Diagnostics orporated For: 28 July By Investing.com - Investing.com South Africa
Quest Diagnostics Inc (DGX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Quest Diagnostics Incorporated (DGX) Stock Forecasts - Yahoo Finance
Quest Diagnostics (NYSE: DGX) SVP adds shares via dividend reinvestment plan - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP acquires 34.0000 shares via dividend reinvestment - Stock Titan
Rothschild & Co Redburn Adjusts Quest Diagnostics Price Target to $251 From $233, Maintains Buy Rating - Moomoo
Quest Diagnostics Incorporated (NYSE:DGX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Quest Diagnostics (DGX) Leads S&P 500 Healthcare Gainers with 8. - GuruFocus
Quest Diagnostics Incorporated (DGX) Stock forecasts - Yahoo Finance Singapore
Why Quest Diagnostics (DGX) Is Up 8.2% After Raising 2026 Guidance And Boosting Buybacks - Yahoo Finance
Quest Diagnostics stock trades steady as earnings and diagnostics demand shape investor focus - Ad-hoc-news.de
Quest Diagnostics Inc (DGX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Quest Diagnostics Inc (DGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Truist Financial Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail
Quest Diagnostics Inc (DGX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Quest Diagnostics Is Maintained at Outperform by Mizuho - Moomoo
Quest Diagnostics Inc (DGX) Cash Flow - TradingKey
DGX|Quest Diagnostics Inc|Price:235.424|Chg%:+1.704 - TradingKey
DGX|Quest Diagnostics Inc|Price:227.860|Chg%:-0.050 - TradingKey
Quest Diagnostics Inc (DGX) Institutional Confidence - TradingKey
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
0.23%
자본화:
|
볼륨(24시간):